StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Oncology — Worldwide product sales by Quarter

Oncology — Worldwide product sales ($M) ($M)

QuarterlyAnnual

AstraZeneca Oncology — Worldwide product sales: $6,713M in Q2 2026, up 14.7% from a year earlier. That is the highest of the 42 quarters on record here.

Latest, Q2 2026
6,713
Period ended Jun 30, 2026
Change on a year earlier
+14.7%
5,854 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

“|| Oncology | 6,713 | | 15 | | 13 | | 3,163 | | 14 | | 1,522 | | 16 | | 12 | | 1,408 | | 19 | | 14 | | 620 | | 5 | | 10”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F Product Sales by Therapy Area & Region Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOncology — Worldwide product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20266,713+14.7%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20266,236+19.2%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 20256,470+21.1%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20256,143+18.2%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20255,854+17.6%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20255,231+9.9%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20245,341+19.9%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20245,197+18.4%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20244,976+13.6%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20244,760+21.4%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20234,453+18.9%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20234,389+15.6%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20234,382+18.4%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20233,920+15.7%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20223,746+8.4%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 20223,797+14.2%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up oncology — Worldwide product sales

Cite this data

StockData. (2026). AstraZeneca Oncology — Worldwide product sales ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta-oncology-world

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.